Alison Halliday, PhD
Dr. Alison Halliday is an award-winning freelance science communications specialist with 20+ years of experience across academia, industry and the third sector – including ten years at the world’s largest cancer charity. She is skilled at translating complex information into jargon-free, engaging, stories – specializing in topics across the life sciences, medicine and health. After completing her PhD in molecular genetics at the University of Newcastle, she carried out five years of postdoctoral research at University College London before moving into science communications. She now works with a variety of clients to bring their research to life – including companies that need support with their product marketing, or organizations looking to engage with their audiences about the latest advances in biomedicine.
Latest Content
Article
Exploiting Epigenetics in Cancer Treatment
Changes to the complex of DNA and the proteins that form chromatin are important drivers in many cancers. We explore the challenges and progress in the development of new therapies targeting epigenetic regulators.
Article
Cancer Biomarkers: the Liquid Biopsy Revolution
非侵入性的液体活检将改变landscape of how cancers are diagnosed and treated in the future. We explore how mass spectrometry is helping researchers discover protein biomarkers in blood and urine, highlight challenges around their validation – and find out how close they are to reaching the clinic.
Article
X-ray Crystallography: Exploring the Frontiers of Structural Biology
For over a century, X-ray crystallography has enabled scientists to elucidate biological structures in exquisite detail. Now, powerful new technologies are bringing unprecedented opportunities to add to the history of breakthroughs in this cutting-edge field.
Article
Metabolomics: The Long Journey from Lab to Clinic
Recent improvements in technology are enabling the simultaneous detection and quantitation of large numbers of metabolites from biological samples. Here, we examine the challenges and innovations in metabolomics technologies and find out how these tools are impacting on clinical biomarker discovery.
Article
Metagenomics: Exploring Microbiomes at Nature’s New Frontiers
Advances in sequencing technologies are providing scientists with a powerful way to view microbial communities in unprecedented detail. Metagenomics is a rapidly evolving field that is uncovering a wealth of hidden biodiversity, revolutionizing our understanding of uncharted corners in the living world.
Article
Proteomics and Cancer: A Powerful New Revolution
In the post-genomics era, we look at the powerful new revolution in proteomics. We find out how advances are deepening our understanding of cancer biology and resistance processes, which will lead to new clinical applications such as non-invasive biomarkers and drug development.
Article
Exploiting Exosomes for Cancer Diagnosis and Treatment
Evidence is mounting for exosomes playing a central role in many aspects of cancer biology. As researchers start to unravel the secrets of these elusive little vesicles, this is opening a host of exciting new opportunities to tackle cancer – from non-invasive diagnostics to innovative new therapeutics.
Article
Making Medicine More Precise Using Metabolomics
The metabolome is exquisitely sensitive to our physiology, sitting at the interface of our genome and environment. Developing handheld devices that enable people to monitor themselves for changes in their metabolites that can predict future disease will empower them to take charge of their own healthcare, transforming medicine.
Article
Capillary Electrophoresis-Mass Spectrometry – The Coming of Age for a Powerful Technique
Capillary electrophoresis-mass spectrometry (CE-MS) has remained in the shadows for decades. However, this powerful separation technique is now enjoying a renaissance, with academic and industrial scientists keen to exploit its key advantages. We spoke to some of its most ardent fans to explore a variety of the latest research and clinical applications.
Article
Industrializing Proteomics to Transform the Future of Healthcare
With very few biomarkers having made it into clinical practice, we find out how some proteomics laboratories are using a factory-type set up to get more biomarkers into the clinic, faster.
Advertisement